Daprodustat for Anaemia in Patients with Heart Failure and Chronic Kidney Disease: A Randomized Controlled Study

Abstract

Considering the hypothetical upside and downside of using HIF-PH inhibitors in anaemic patients with HF and chronic kidney disease, and because there are virtually no safe and effective treatments for patients with anaemia not caused by iron deficiency, our study results will contribute significantly to this field.